Furosemide Export Market Intelligence: India's 333 Suppliers Shipping to 150 Countries — TransData Nexus 2026

Q: Who are the top furosemide exporters from India?

The top furosemide exporters from India are: 1. BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED — $17.8M (25.2% market share); 2. GRAVITI PHARMACEUTICALS PRIVATE LIMITED — $14.3M (20.3% market share); 3. IPCA LABORATORIES LIMITED — $3.4M (4.8% market share); 4. PFIZER HEALTHCARE INDIA PRIVATE LIMITED — $2.8M (3.9% market share); 5. AVET LIFESCIENCES PRIVATE LIMITED — $2.7M (3.8% market share). Together they account for 58.0% of India's total furosemide export value.

Q: What is the total export value of furosemide from India?

The total export value of furosemide from India is $70.5M USD, recorded across 4,657 shipment transactions from 333 active exporters to 150 destination countries. The average shipment value is $15.1K.

Q: Which countries import furosemide from India?

India exports furosemide to 150 countries worldwide. The top importing countries are: UNITED STATES (60.2% share, $42.5M), CANADA (7.3% share, $5.1M), FRANCE (6.2% share, $4.3M), GERMANY (2.9% share, $2.1M), SOUTH AFRICA (2.2% share, $1.6M). These five markets account for 78.8% of total export value.

Q: What is the HS code for furosemide exports from India?

The primary HS code for furosemide exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of furosemide exports from India?

The average unit price for furosemide exports from India is $1.74 USD per unit, with prices ranging from $0.00 to $1018.62 depending on formulation, packaging, and order volume. The total market is valued at $70.5M across 4,657 shipments.

Q: Which ports handle furosemide exports from India?

The primary ports for furosemide exports from India are HYDERABAD ICD (17.8% of shipments), HYDERABAD ICD (INSNF6) (11.3% of shipments), SAHAR AIR (9.0% of shipments), SAHAR AIR CARGO ACC (INBOM4) (8.6% of shipments), NHAVA SHEVA SEA (INNSA1) (6.7% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of furosemide?

India is one of the world's leading exporters of furosemide due to its large base of 333 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports furosemide to 150 countries, demonstrating 77% global market coverage.

Q: What certifications do Indian furosemide exporters need?

Indian furosemide exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import furosemide from India?

There are 778 registered buyers importing furosemide from India, spread across 150 countries. The repeat buyer rate is 47.0%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top furosemide supplier from India?

BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED is the leading furosemide exporter from India with a market share of 25.2% and total export value of $17.8M across 142 shipments. The top 5 suppliers together control 58.0% of total export value.

Suresh Sormare

Furosemide

India Pharmaceutical Trade Intelligence

$70.5M333 Suppliers150 CountriesHS 30049099

ExportsIndia → UNITED STATES60.2%India → CANADA7.3%

ImportsCANADA → India$79.8K GERMANY → India$43.9K

#1 Supplier: BAXTER PHARMACEUTICALS #1 Buyer: BAXTER HEALTHCARE

How India Exports Furosemide to the World

Between 2022 and 2026, India exported $70.5M worth of furosemide across 4,657 verified shipments to 150 countries — covering 77% of world markets in the Diuretics segment. The largest destination is UNITED STATES (60.2%). BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED leads with a 25.2% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Furosemide export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Furosemide export data snapshot — $70.5M · 333 exporters · 150 countriesTransData Nexus · Indian Customs Data

Top Furosemide Exporters from India

333 active exporters · Ranked by export value

View all 333 →

Top Furosemide Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED	$17.8M	142	12	25.2%
2	GRAVITI PHARMACEUTICALS PRIVATE LIMITED

Top Countries Importing Furosemide from India

150 destination markets · Ranked by import value

All 150 countries →

Top Countries Importing Furosemide from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$42.5M	60.2%
2	CANADA	$5.1M	7.3%
3	FRANCE	$4.3M	6.2%
4	GERMANY	$2.1M	2.9%
5	SOUTH AFRICA	$1.6M	2.2%
6	TANZANIA	$1.6M	2.2%
7	MALTA	$1.4M	1.9%
8	AUSTRALIA	$1.2M	1.7%
9	SRI LANKA	$930.0K	1.3%
10	MYANMAR	$668.9K	0.9%

UNITED STATES is India's largest furosemide export destination, absorbing 60.2% of total exports worth $42.5M. The top 5 importing countries — UNITED STATES, CANADA, FRANCE, GERMANY, SOUTH AFRICA — together account for 78.8% of India's total furosemide export value. The remaining 145 destination countries collectively receive the other 21.2%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Furosemide to India?

12 origin countries · Total import value: $132.8K

India imports furosemide from 12 countries with a combined import value of $132.8K. The largest supplier is CANADA ($79.8K, 30 shipments), followed by GERMANY and FRANCE. All values are from Indian Customs (DGFT) import records.

Countries Supplying Furosemide to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	CANADA	$79.8K	30	60.0%
2	GERMANY	$43.9K	11	33.1%
3	FRANCE	$3.8K	12	2.9%
4	UNITED STATES	$3.1K	21	2.4%
5	UNITED KINGDOM	$713	10	0.5%
6	NETHERLANDS	$641	2	0.5%
7	HUNGARY	$524	21	0.4%
8	POLAND	$213	16	0.2%
9	SOUTH AFRICA	$49	1	0.0%
10	BELGIUM	$23	1	0.0%

Showing top 10 of 12 origin countries

CANADA is the largest supplier of furosemide to India, accounting for 60.0% of total import value. The top 5 origin countries — CANADA, GERMANY, FRANCE, UNITED STATES, UNITED KINGDOM — together supply 98.9% of India's furosemide imports. Click any country to see detailed supplier and buyer data for that import corridor.

Furosemide — Export Intelligence Video

Visual overview of India's furosemide import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's furosemide pharmaceutical import and export market — $70.5M in total trade, 333 verified manufacturers, and 150 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Furosemide

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, furosemide is approved under multiple Abbreviated New Drug Applications (ANDAs), indicating a well-established generic market. The FDA's Orange Book lists numerous approved ANDAs for furosemide, reflecting its widespread acceptance and use. The regulatory pathway for importing furosemide into the U.S. requires compliance with FDA standards, including facility registration, product listing, and adherence to current Good Manufacturing Practices (cGMPs). Importers must file an entry notice and bond with U.S. Customs, and the FDA verifies compliance upon importation. As of March 2026, there are no specific import alerts related to furosemide from India, indicating a favorable compliance status for Indian exporters.

2EU & UK Regulatory Framework

In the European Union, furosemide is subject to marketing authorization by the European Medicines Agency (EMA). A notable case is the EMA's assessment of Furosemide Vitabalans, where the Committee for Medicinal Products for Human Use (CHMP) concluded in October 2012 that the benefits did not outweigh the risks, leading to a refusal of marketing authorization in several member states. This underscores the stringent evaluation processes within the EU. Manufacturers exporting to the EU and UK must comply with Good Manufacturing Practice (GMP) standards, ensuring product quality and safety. (ema.europa.eu)

3WHO Essential Medicines & Global Standards

Furosemide is included in the World Health Organization's Model List of Essential Medicines, highlighting its critical role in healthcare systems worldwide. It is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality and efficacy across different regions.

4India Regulatory Classification

In India, furosemide is classified under Schedule H of the Drugs and Cosmetics Act, indicating it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates its price to ensure affordability. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for exporting furosemide, ensuring compliance with national regulations.

5Patent & Exclusivity Status

Furosemide's patents have long expired, leading to a robust generic market with significant competition. This has resulted in widespread availability and competitive pricing globally.

6Recent Industry Developments

In June 2025, the FDA issued import alerts for certain medical devices manufactured in Japan by Olympus Medical Systems Corporation due to quality system regulation violations. While not directly related to furosemide, this highlights the FDA's stringent oversight on imported medical products.

In September 2024, the FDA requested Azurity Pharmaceuticals Inc. to stop distributing unapproved drugs marketed as "Unit-of-Use Prescription Compounding Kits," emphasizing the agency's commitment to ensuring that all marketed drugs have proven safety and efficacy.

These developments underscore the importance of regulatory compliance and the FDA's proactive stance in safeguarding public health.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Supply Chain Risk Assessment — Furosemide

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, renowned as the "pharmacy of the world," heavily relies on China for Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs). Approximately 70% of India's imported bulk drugs, including APIs and KSMs, originate from China. This dependency is particularly concerning for essential medications like Furosemide, where the supply chain's upstream components are predominantly sourced from Chinese manufacturers.

The COVID-19 pandemic in early 2020 exposed the vulnerabilities of this reliance. Disruptions in Chinese manufacturing led to significant shortages and price volatility in APIs, impacting global pharmaceutical production. Despite initiatives like India's Production Linked Incentive (PLI) scheme, launched in July 2020 to bolster domestic API and KSM production, the industry continues to grapple with challenges such as cost competitiveness and infrastructure limitations.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters account for 58.0% of Furosemide exports, with BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED leading at a 25.2% share. This concentration poses a significant risk, as disruptions affecting these key suppliers could severely impact global Furosemide availability.

The PLI scheme, initiated in July 2020, aims to reduce such dependencies by incentivizing domestic production of critical APIs and KSMs. However, the effectiveness of this initiative remains to be fully realized, as the industry continues to face challenges in scaling up production to meet both domestic and international demand.

Access Complete Furosemide Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 4,657 transactions across 150 markets.

Request Demo View Pricing

Frequently Asked Questions — Furosemide Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top furosemide exporters from India?

The leading furosemide exporters from India are BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, GRAVITI PHARMACEUTICALS PRIVATE LIMITED, IPCA LABORATORIES LIMITED, and 12 others. BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED leads with 25.2% market share ($17.8M). The top 5 suppliers together control 58.0% of total export value.

What is the total export value of furosemide from India?

The total export value of furosemide from India is $70.5M, recorded across 4,657 shipments from 333 active exporters to 150 countries. The average shipment value is $15.1K.

Which countries import furosemide from India?

India exports furosemide to 150 countries. The top importing countries are UNITED STATES (60.2%), CANADA (7.3%), FRANCE (6.2%), GERMANY (2.9%), SOUTH AFRICA (2.2%), which together account for 78.8% of total export value.

What is the HS code for furosemide exports from India?

The primary HS code for furosemide exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Furosemide Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

Furosemide

Furosemide

How India Exports Furosemide to the World

Top Furosemide Exporters from India

Top Countries Importing Furosemide from India

Who Supplies Furosemide to India?

Quick Facts

Related Diuretics

Related Analysis

Need Details?

Furosemide — Export Intelligence Video

Regulatory Landscape — Furosemide

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Supply Chain Risk Assessment — Furosemide

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Furosemide Trade Intelligence

Frequently Asked Questions — Furosemide Exports from India

Who are the top furosemide exporters from India?

What is the total export value of furosemide from India?

Which countries import furosemide from India?

What is the HS code for furosemide exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of furosemide exports from India?

Which ports handle furosemide exports from India?

Why is India a leading exporter of furosemide?

What certifications do Indian furosemide exporters need?

How many buyers import furosemide from India?

What is the market share of the top furosemide exporter from India?

Analysis Methodology